Mirae Asset Global Etfs Holdings Ltd. Abeona Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,906 shares of ABEO stock, worth $129,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,906Holding current value
$129,331% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABEO
# of Institutions
103Shares Held
31.6MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$23.6 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$16.6 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$14.5 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$13.6 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$11.3 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $32.2M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...